Journal article
Dimercaptosuccinic acid in the treatment of depression following lead exposure
American journal of industrial medicine, Vol.24(6), pp.701-706
12/1993
DOI: 10.1002/ajim.4700240606
PMID: 8311100
Abstract
Long‐term exposure to lead is known to cause a variety of neurotoxic manifestations, including symptoms of depression. Dimercaptosuccinic acid (DMSA), a recently approved oral chelating agent, can diminish the body burden of lead, but few cases of documented clinical improvement following treatment have been reported. We report a case of moderate to severe depression in a long‐term lead worker that appeared to respond dramatically to DMSA. This response suggests a possible therapeutic role for DMSA in the treatment of depression in lead‐exposed patients. © 1993 Wiley‐Liss, Inc. Copyright © 1993 Wiley Periodicals, Inc., A Wiley Company
Details
- Title: Subtitle
- Dimercaptosuccinic acid in the treatment of depression following lead exposure
- Creators
- Howard Frumkin - Emory UniversityFredric Gerr - Emory University
- Resource Type
- Journal article
- Publication Details
- American journal of industrial medicine, Vol.24(6), pp.701-706
- Publisher
- Wiley Subscription Services, Inc., A Wiley Company
- DOI
- 10.1002/ajim.4700240606
- PMID
- 8311100
- ISSN
- 0271-3586
- eISSN
- 1097-0274
- Number of pages
- 6
- Language
- English
- Date published
- 12/1993
- Academic Unit
- Occupational and Environmental Health; Epidemiology
- Record Identifier
- 9984364401202771
Metrics
7 Record Views